Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.

Bota DA, Piccioni DE, Duma CM, Kesari S, Carrillo JA, LaRocca RV, Aiken RD, Taylor TH, Abedi M, Robles RM, Godding K, Keirstead HS, Nistor GI, Dillman RO

Open source

DOI: 10.1080/21645515.2025.2556591
Published: 2025 Dec
Container: Human vaccines & immunotherapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2025.2556591,
  title = {Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.},
  author = {Bota DA and Piccioni DE and Duma CM and Kesari S and Carrillo JA and LaRocca RV and Aiken RD and Taylor TH and Abedi M and Robles RM and Godding K and Keirstead HS and Nistor GI and Dillman RO},
  year = {2025},
  journal = {Human vaccines \& immunotherapeutics},
  doi = {10.1080/21645515.2025.2556591},
  url = {https://doi.org/10.1080/21645515.2025.2556591}
}

RIS

TY  - JOUR
TI  - Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.
AU  - Bota DA
AU  - Piccioni DE
AU  - Duma CM
AU  - Kesari S
AU  - Carrillo JA
AU  - LaRocca RV
AU  - Aiken RD
AU  - Taylor TH
AU  - Abedi M
AU  - Robles RM
AU  - Godding K
AU  - Keirstead HS
AU  - Nistor GI
AU  - Dillman RO
PY  - 2025
JO  - Human vaccines & immunotherapeutics
DO  - 10.1080/21645515.2025.2556591
UR  - https://doi.org/10.1080/21645515.2025.2556591
ER  -

APA

DA, B., DE, P., CM, D., S, K., JA, C., RV, L., RD, A., TH, T., M, A., RM, R., K, G., HS, K., GI, N., & RO, D. (2025). Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.. Human vaccines & immunotherapeutics. https://doi.org/10.1080/21645515.2025.2556591

Source records

pubmed · retrieved 2026-09-26T12:32:33.029Z
europe-pmc · retrieved 2026-09-26T12:32:33.019Z
doaj · retrieved 2026-09-26T12:32:33.016Z